Pioneering doctor reflects on gene therapy’s trajectory

November 23, 2016

Alessandra Biffi

“There were a lot of expectations 20 years ago, then there was a big drop related to side effects,” Alessandra Biffi, MD, director of gene therapy at Dana-Farber/Boston Children’s, tells New Scientist.

“Now everybody is again climbing to the top of the hill. But whether there is too much or too little enthusiasm doesn’t change the fact that development of gene therapy as a treatment is a process.”

Media Inquiries

Brendan Monahan
Manager, Media Relations
617-632-5653
brendanj_monahan@dfci.harvard.edu

Follow Us!

Stay updated on our latest news and developments by following us on Twitter.

Twitter Logo